# AstraZeneca PLC (AZN.L): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/azn.l for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - General
- Exchange: LSE · Trading currency: GBX

AstraZeneca PLC operates as a biopharmaceutical company, specializing in the discovery, development, manufacturing, and commercialization of prescription medications. Its comprehensive portfolio addresses diverse therapeutic areas. In oncology, key marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex. For cardiovascular, renal, and metabolism diseases, the company offers treatments such as Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, O...

## Quote & Key Metrics

As of 2026-11-20:

| Metric | Value |
|---|---|
| Price | GBX 13,412.00 GBX |
| Market Cap | GBX 20.80T |
| P/E (TTM) | 17.81 |
| EPS (TTM) | GBX 753.00 |
| 52-Week Range | GBX 9,892.00 – GBX 15,732.00 |
| Dividend Yield (TTM) | 1.78% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 1.78% |
| Annual Dividend (TTM) | GBX 239.00 /share |
| Annual Dividend (Forward) | GBX 239.00 /share |
| Frequency | Semi-Annual |
| Consecutive Growth Streak | 0 years |
| Growth CAGR 1Y / 3Y / 5Y | 3.7% / 12.0% / 11.2% |
| Payout Ratio (EPS, TTM) | 45.1% |
| Payout Ratio (FCF, TTM) | 54.7% |
| Payout Ratio (EPS, forward dividend) | 45.1% |
| Payout Ratio (FCF, forward dividend) | 54.7% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-08-06 | GBX 79.5000 | 2026-09-08 |
| 2026-02-19 | GBX 159.5000 | 2026-03-23 |
| 2025-08-07 | GBX 76.7000 | 2025-09-08 |
| 2025-02-20 | GBX 168.0000 | 2025-03-24 |
| 2024-08-08 | GBX 60.8151 | 2024-09-09 |
| 2024-02-22 | GBX 123.2533 | 2024-03-25 |
| 2023-08-10 | GBX 56.5353 | 2023-09-11 |
| 2023-02-23 | GBX 135.3015 | 2023-03-27 |
| 2022-08-11 | GBX 76.4000 | 2022-09-12 |
| 2022-02-24 | GBX 108.0102 | 2022-03-28 |
| 2021-08-12 | GBX 46.8166 | 2021-09-13 |
| 2021-02-25 | GBX 97.9955 | 2021-03-29 |

Five years of payments, yield history and payout by year: https://www.dividenddata.com/stocks/azn.l/dividend.md

## Frequently Asked Questions

### What does AstraZeneca PLC do?

AstraZeneca PLC (AZN.L) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is AZN.L's market cap?

AstraZeneca PLC (AZN.L) has a market capitalization of approximately GBX 20.80 trillion, as of November 20, 2026, based on the most recent share price and shares outstanding.

### Does AZN.L pay a dividend?

Yes, AstraZeneca PLC (AZN.L) pays a dividend semi-annually, with a trailing-twelve-month yield of 1.78%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does AZN.L pay dividends?

AstraZeneca PLC pays dividends semi-annually. The forward annual rate is GBX 239.00 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is AZN.L's payout ratio?

AstraZeneca PLC's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## Ask an AI Agent About AZN.L

With the Dividend Data MCP connector, an AI agent answers questions about AZN.L from the same data as this page and links the page behind each number.

- Connector address: https://www.dividenddata.com/mcp (add it as a custom connector, also called an MCP server, then sign in)
- Setup for Claude, ChatGPT, Grok, Gemini, Cursor and any MCP client: https://www.dividenddata.com/connections
- A free Dividend Data account connects. The agent gets what the account's plan gets on the site.

### The Tool Behind Each Page

| Page | MCP tools |
|---|---|
| Overview: https://www.dividenddata.com/stocks/azn.l | `stock_summary`, `stock_price_history` |
| Dividend: https://www.dividenddata.com/stocks/azn.l/dividend | `stock_dividends` |
| Earnings & estimates: https://www.dividenddata.com/stocks/azn.l/earnings | `stock_earnings`, `stock_estimates` |
| Financials: https://www.dividenddata.com/stocks/azn.l/financials/income | `stock_financials`, `stock_debt_maturity` |
| Full statements: https://www.dividenddata.com/stocks/azn.l/statements | `stock_statements` |
| Valuation: https://www.dividenddata.com/stocks/azn.l/valuation | `stock_valuation` |
| Peers: https://www.dividenddata.com/stocks/azn.l/peers | `stock_peers` |

### Questions to Ask

- Using Dividend Data, compare AZN.L's 5-year price return with its revenue and EPS growth over the same years. Which grew faster, and is the stock more or less expensive than 5 years ago?
- Using Dividend Data, summarize AZN.L's dividend history: the current annual payout, its 5-year and 10-year growth rates, and every cut or pause.
- Using Dividend Data, how does AZN.L's dividend yield today compare with its 5-year and 10-year averages? What moved it, the price or the dividend?
- Using Dividend Data, how has AZN.L's FCF payout ratio changed over the last 10 years, and is the dividend covered today?
- Using Dividend Data, walk through AZN.L's income statement for the last 3 fiscal years: revenue growth, margins, and what changed.
- Using Dividend Data, is AZN.L's P/E ratio high or low today against its own 5-year and 10-year averages? What changed?
- Using Dividend Data, how strong is AZN.L's balance sheet? Look at cash, debt and equity, and how they changed over 5 years.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/azn.l
- Dividend history & safety: https://www.dividenddata.com/stocks/azn.l/dividend (Markdown: https://www.dividenddata.com/stocks/azn.l/dividend.md)
- Earnings & EPS: https://www.dividenddata.com/stocks/azn.l/earnings
- Financial statements: https://www.dividenddata.com/stocks/azn.l/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/azn.l/valuation
- Peer comparison: https://www.dividenddata.com/stocks/azn.l/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.